Stocks · News reference

Haleon Cuts Full-Year Organic Revenue Growth Guidance

Oct 29, 2026, 2:01 PM

Haleon has lowered its full-year organic revenue growth outlook to approximately 2.5%, down from its previous forecast of 3% to 5%, citing weaker-than-expected sales in its respiratory health category.

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

HLN

Source: fiscal.ai
Observed: Oct 29, 2026, 2:01 PM
Checked: Oct 29, 2026, 2:02 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaOct 29, 2026, 2:16 PMBenzinga Newsdesk
Haleon Adjusts FY26 Organic Revenue Growth To ~2.5%, High-Single-Digit Adjusted Operating Profit Growth At Constant Currency, Net Interest Of ~£255 Million, Incorporating China Centrum OTC Product Classification Changes And Accelerated Brazil Go-To-Market Model Rollout
HLN
BenzingaOct 29, 2026, 2:13 PMVandana Singh
Consumer Healthcare Giant Haleon Plunges to 52-Week Low
Haleon shares hit a 52-week low as the company trimmed full-year sales targets to 2.5% amid China import halts and Brazil adjustments.
HLN
BenzingaOct 29, 2026, 2:13 PMBenzinga Newsdesk
Haleon Commences £500 Million Share Buyback Program
HLN

Haleon Cuts Full-Year Organic Revenue Growth Guidance

Connected Markets

Related Headlines

Haleon Adjusts FY26 Organic Revenue Growth To ~2.5%, High-Single-Digit Adjusted Operating Profit Growth At Constant Currency, Net Interest Of ~£255 Million, Incorporating China Centrum OTC Product Classification Changes And Accelerated Brazil Go-To-Market Model Rollout

Consumer Healthcare Giant Haleon Plunges to 52-Week Low

Haleon Commences £500 Million Share Buyback Program